Haleon (HLN) Cash from Discontinued Operations (2021 - 2025)
Haleon's (HLN) quarterly Cash from Discontinued Operations came in at 1375981679.77 in Q4 2025, up 48.02% on a QoQ basis from 929622762.15 in Q4 2023.
Haleon (HLN) Cash from Discontinued Operations (2021 - 2025) Analysis & Trends
Haleon (HLN) has 4 years of Cash from Discontinued Operations data on file, last reported at 1375981679.77 in Q4 2025.
- Quarterly Cash from Discontinued Operations changed N/A year-over-year to 1375981679.77 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3940476317.83 (changed N/A YoY) and the FY2024 annual result came in at 2941311634.91, up 12.61% from the prior year.
- Cash from Discontinued Operations improved to 1375981679.77 in Q4 2025, from 929622762.15 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 1375981679.77 in Q4 2025 to a low of 315434482.08 in Q4 2021.
- A 4-year average of 851182159.98 and a median of 837280617.53 in 2022 frame the typical range for Cash from Discontinued Operations.
- Annual changes were most pronounced in 2022 — Cash from Discontinued Operations surged 152.85% — and 2023, when it grew 16.55%.
- Tracing HLN's Cash from Discontinued Operations over 4 years: stood at 315434482.08 in 2021, then surged by 152.85% to 797591258.37 in 2022, then gained by 16.55% to 929622762.15 in 2023, then surged by 48.02% to 1375981679.77 in 2025.
- The last three Cash from Discontinued Operations figures came in at 1375981679.77 (Q4 2025), 929622762.15 (Q4 2023), and 797591258.37 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.21 Bn | 39.55 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.48 Bn | 29.80 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.49 Bn | 15.10 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.38 Bn |
| Dec 31, 2025 | 1.38 Bn |
| Dec 31, 2023 | 929.62 Mn |
| Dec 31, 2023 | 929.62 Mn |
| Dec 31, 2022 | 797.59 Mn |
| Dec 31, 2022 | 797.59 Mn |
| Sep 20, 2022 | 837.28 Mn |
| Sep 20, 2022 | 837.28 Mn |
| Dec 31, 2021 | 315.43 Mn |
| Dec 31, 2021 | 315.43 Mn |